Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Dietmar Bänsch Added: 3 years ago
For more than three decades, the implantable cardioverter defibrillator (ICD) has proven to be a well-established, main therapeutic tool for the primary and secondary prevention of sudden cardiac death due to malignant ventricular arrhythmias.1 One of the standard practice concepts is defibrillation (DF) testing. Defibrillation testing has been considered a mandatory part at the time of… View more
Author(s): Justin Hayase , Duc H Do , Noel G Boyle Added: 3 years ago
The ICD is an important therapy for both primary and secondary prevention of sudden cardiac death in selected patients. The role for defibrillation threshold (DFT) testing either intraoperatively or postoperatively has changed significantly over the past few decades, and it is no longer routinely recommended in patients undergoing left-sided transvenous ICD implantation.1–7 The definition of the… View more
Author(s): Lorenzo Gianquintieri Added: 4 years ago
Lorenzo Gianquintieri (Politecnico di Milano, IT) discusses optimising Public-Access Defibrillation programs using Geographic Information Systems analysis Filmed on site at ESC Digital Summit in Tallinn by Radcliffe Cardiology. QUESTIONS 1. What research are you conducting on optimising Public-Access Defibrillation programs using GIS analysis? 2. What are some of the key findings that have… View more
Author(s): Kathy L Lee Added: 3 years ago
All pacing leads are associated with complications such as infection, fracture, failure and dislodgement. Lead extraction is a high-risk procedure. With new device systems that often require implantation of multiple leads and with patients living longer, the incidence of lead complications is becoming compounded over time.1 Therefore, there is a strong demand to develop a pacing system that… View more
Added: 3 years ago Source:  BIOTRONIK
Large, Randomized Trial Demonstrates Excellent Shock Efficacy of BIOTRONIK Implantable Cardioverter-Defibrillators BERLIN, Germany, September 04, 2015 – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, today announced the publication of NORDIC ICD (NO Regular Defibrillation testing In Cardioverter-Defibrillator Implantation) trial results in the European Heart Journal. The… View more
Author(s): Stacey Neuman , Micheal P Howard , John D Day Added: 3 years ago
Implantable cardioverter–defibrillators (ICDs) are being implanted in an ever-increasing number of patients at risk for sudden cardiac death. To ensure the efficacy of the defibrillation system, step-down defibrillation threshold (DFT) testing has traditionally been used to ensure that the ICD can appropriately detect and terminate clinical ventricular fibrillation (VF). Currently, the most… View more
Author of more than 120 scientific communications (of which more than 50 in International Congresses). Author of more than 20 articles published, most in International journals Associate investigator of multiple multicentre clinical trials and national and international registries Assistant of the course of Introduction to the Clinic (3rd year, Faculty of Medicine of Lisbon). Professor and… View more
Added: 2 months ago Source:  Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
RAFT, a new extended follow-up trial (NCT00251251) showed insight into the survival benefit associated with coronary resynchronization therapy defibrillator (CRT-D) as compared to implantable cardioverter-defibrillator (ICD) in patients with heart failure.Methodology:The Resynchronization/Defibrillation for Ambulatory Heart Failure Trial (RAFT) is a randomized trial which aimed to compare the… View more
Added: 3 years ago Source:  escardio
Italian law must change to improve survival from cardiac arrest Law requiring certificate to use a defibrillator reduces response time Milan, Italy – 5 March 2018: An Italian law requiring citizens to hold a certificate to use a defibrillator must change to improve survival from cardiac arrest, researchers argued today at Acute Cardiovascular Care 2018, a European Society of Cardiology congress.1… View more